ArticleOxidative medicine and cellular longevity2022

RBM10 Is a Biomarker Associated with Pan-Cancer Prognosis and Immune Infiltration: System Analysis Combined with In Vitro and Vivo Experiments.

Yingyue Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.